{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T21:49:40Z","timestamp":1786225780035,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA230155"],"award-info":[{"award-number":["K08 CA230155"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate cancer. We sought to qualitatively characterize how physicians communicate SE in consultations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We transcribed 50 initial prostate cancer treatment consultations across nine multidisciplinary providers (Urologists, Radiation Oncologists, Medical Oncologists) at our tertiary referral, academic center. Coders identified quotes describing SE and used an inductive approach to establish a hierarchy for granularity of communication: (1) not mentioned, (2) name only, (3) generalization(\u201chigh\u201d), (4) average incidence without timepoint, (5) average incidence with timepoint, and (6) precision estimate. We reported the most granular mode of communication for each SE throughout the consultation overall and across specialty and tumor risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among consultations discussing surgery (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940), erectile dysfunction (ED) and urinary incontinence (UI) were omitted in 15% and 12%, not quantified (name only or generalization) in 47% and 30%, and noted as average incidence without timeline in 8% and 8%, respectively. In only 30% and 49% were ED and UI quantified with timeline (average incidence with timeline or precision estimate), respectively. Among consultations discussing radiation (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200936), irritative urinary symptoms, ED, and other post-radiotherapy SE were omitted in 22%, 42%, and 64\u201367%, not quantified in 61%, 33%, and 23\u201328%, and noted as average incidence without timeline in 8%, 22%, and 6\u20138%, respectively. In only 3\u20138% were post-radiotherapy SE quantified with timeline. Specialty concordance (but not tumor risk) was associated with higher granularity of communication, though physicians frequently failed to quantify specialty-concordant SE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SE was often omitted, not quantified, and\/or lacked a timeline in treatment consultations in our sample. Physicians should articulate, quantify, and assign a timeline for SE to optimize SDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41391-024-00806-2","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T13:03:16Z","timestamp":1708693396000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Variation in communication of side effects in prostate cancer treatment consultations"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-3272","authenticated-orcid":false,"given":"Timothy J.","family":"Daskivich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-0238","authenticated-orcid":false,"given":"Aurash","family":"Naser-Tavakolian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-0614","authenticated-orcid":false,"given":"Nadine","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhi","family":"Venkataramana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Khodyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Posadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-5769","authenticated-orcid":false,"given":"Howard","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-6419","authenticated-orcid":false,"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"806_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA\/ASTRO guideline, Part I: Introduction, risk assessment, staging, and risk-based management. J Urol. 2022;208:10\u20138. https:\/\/doi.org\/10.1097\/JU.0000000000002757.","journal-title":"J Urol"},{"key":"806_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jama.2014.10186","volume":"312","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision-making. JAMA. 2014;312:1295\u20136. https:\/\/doi.org\/10.1001\/jama.2014.10186.","journal-title":"JAMA"},{"key":"806_CR3","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1001\/jama.2013.281422","volume":"310","author":"VM Montori","year":"2013","unstructured":"Montori VM, Brito JP, Murad MH. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA. 2013;310:2503\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281422.","journal-title":"JAMA"},{"key":"806_CR4","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317:2532\u201342. https:\/\/doi.org\/10.1001\/jama.2017.7248.","journal-title":"JAMA"},{"key":"806_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/cncr.29101","volume":"121","author":"DS Wang","year":"2015","unstructured":"Wang DS, Jani AB, Sesay M, Tai CG, Lee DK, Echt KV, et al. Video-based educational tool improves patient comprehension of common prostate health terminology. Cancer. 2015;121:733\u201340. https:\/\/doi.org\/10.1002\/cncr.29101.","journal-title":"Cancer"},{"key":"806_CR6","doi-asserted-by":"publisher","unstructured":"Daskivich TJ, Gale R, Luu M, Naser-Tavakolian A, Venkataramana A, Khodyakov D, et al. Variation in communication of competing risks of mortality in prostate cancer treatment consultations. J Urol. 2022. https:\/\/doi.org\/10.1097\/JU.0000000000002675.","DOI":"10.1097\/JU.0000000000002675"},{"key":"806_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.5803","author":"TJ Daskivich","year":"2021","unstructured":"Daskivich TJ, Gale R, Luu M, Khodyakov D, Anger JT, Freedland SJ, et al. Patient preferences for communication of life expectancy in prostate cancer treatment consultations. JAMA Surg. 2021. https:\/\/doi.org\/10.1001\/jamasurg.2021.5803.","journal-title":"JAMA Surg"},{"key":"806_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.2517-6161.1968.tb00759.x","volume":"30","author":"ACA Hope","year":"1968","unstructured":"Hope ACA. A simplified Monte Carlo significance test procedure. J R Stat Soc. 1968;30:582\u2013298.","journal-title":"J R Stat Soc"},{"key":"806_CR9","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.juro.2013.12.008","volume":"191","author":"SM Gilbert","year":"2014","unstructured":"Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, et al. Satisfaction with information used to choose prostate cancer treatment. J Urol. 2014;191:1265\u201371. https:\/\/doi.org\/10.1016\/j.juro.2013.12.008.","journal-title":"J Urol"},{"key":"806_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/pcan.2010.33","volume":"13","author":"TJ Daskivich","year":"2010","unstructured":"Daskivich TJ, van de Poll-Franse LV, Kwan L, Sadetsky N, Stein DM, Litwin MS. From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer. Prostate Cancer Prostatic Dis. 2010;13:320\u20137. https:\/\/doi.org\/10.1038\/pcan.2010.33.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"806_CR11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1001\/jama.2017.1704","volume":"317","author":"DA Barocas","year":"2017","unstructured":"Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA. 2017;317:1126\u201340. https:\/\/doi.org\/10.1001\/jama.2017.1704.","journal-title":"JAMA"},{"key":"806_CR12","doi-asserted-by":"publisher","unstructured":"Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, et al. Hypofractionated radiation therapy for localized prostate cancer: an ASTRO, ASCO, and AUA evidence-based guideline. J Clin Oncol. 2018:JCO1801097. https:\/\/doi.org\/10.1200\/JCO.18.01097.","DOI":"10.1200\/JCO.18.01097"},{"key":"806_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1200\/JCO.2003.05.169","volume":"21","author":"JC Hu","year":"2003","unstructured":"Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003;21:401\u20135.","journal-title":"J Clin Oncol"},{"key":"806_CR14","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1200\/JCO.2007.12.2721","volume":"25","author":"RW Ross","year":"2007","unstructured":"Ross RW, Kantoff PW. Predicting outcomes in prostate cancer: how many more nomograms do we need? J Clin Oncol. 2007;25:3563\u20134. https:\/\/doi.org\/10.1200\/JCO.2007.12.2721.","journal-title":"J Clin Oncol"},{"key":"806_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/JU.0000000000001355","volume":"205","author":"HJ Tan","year":"2021","unstructured":"Tan HJ, Zhou X, Spratte BN, McMahon S, Nielsen ME, Lund J, et al. Patient reported vs claims based measures of health for modeling life expectancy in men with prostate cancer. J Urol. 2021;205:434\u201340. https:\/\/doi.org\/10.1097\/JU.0000000000001355.","journal-title":"J Urol"},{"key":"806_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2217\/cer.13.34","volume":"2","author":"DA Barocas","year":"2013","unstructured":"Barocas DA, Chen V, Cooperberg M, Goodman M, Graff JJ, Greenfield S, et al. Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study. J Comp Eff Res. 2013;2:445\u201360. https:\/\/doi.org\/10.2217\/cer.13.34.","journal-title":"J Comp Eff Res"},{"key":"806_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1209978","volume":"368","author":"MJ Resnick","year":"2013","unstructured":"Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436\u201345. https:\/\/doi.org\/10.1056\/NEJMoa1209978.","journal-title":"N Engl J Med"},{"key":"806_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa074311","volume":"358","author":"MG Sanda","year":"2008","unstructured":"Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250\u201361. https:\/\/doi.org\/10.1056\/NEJMoa074311.","journal-title":"N Engl J Med"},{"key":"806_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jama.283.3.354","volume":"283","author":"JL Stanford","year":"2000","unstructured":"Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study. JAMA. 2000;283:354\u201360. https:\/\/doi.org\/10.1001\/jama.283.3.354.","journal-title":"JAMA"},{"key":"806_CR20","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/djh259","volume":"96","author":"AL Potosky","year":"2004","unstructured":"Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96:1358\u201367. https:\/\/doi.org\/10.1093\/jnci\/djh259.","journal-title":"J Natl Cancer Inst."},{"key":"806_CR21","doi-asserted-by":"publisher","first-page":"e2223025","DOI":"10.1001\/jamanetworkopen.2022.23025","volume":"5","author":"HP Bagshaw","year":"2022","unstructured":"Bagshaw HP, Arnow KD, Trickey AW, Leppert JT, Wren SM, Morris AM. Assessment of second primary cancer risk among men receiving primary radiotherapy vs surgery for the treatment of prostate cancer. JAMA Netw Open. 2022;5:e2223025 https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.23025.","journal-title":"JAMA Netw Open"},{"key":"806_CR22","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1200\/JCO.2001.19.9.2517","volume":"19","author":"AS Hamilton","year":"2001","unstructured":"Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the prostate cancer outcomes study. J Clin Oncol. 2001;19:2517\u201326. https:\/\/doi.org\/10.1200\/JCO.2001.19.9.2517.","journal-title":"J Clin Oncol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00806-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00806-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00806-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T02:58:16Z","timestamp":1740452296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00806-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1038\/s41391-024-00806-2","relation":{"is-basis-for":[{"id-type":"doi","id":"10.52843\/cassyni.7tlpby","asserted-by":"object"}]},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"22 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}